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INTRODUCTION
Kawasaki disease (KD) is an acute multisystem vasculitis
that afflicts mostly young children. Since the first report of
KD in 1967 (1), many attempts to determine the etiology
of the disease have failed. However, the clinical and epidemi-
ologic studies have proposed that KD is closely related to an
infectious disease (2, 3). The acute onset of a self-limited co-
urse, the prevalent population (rare in <6 months of age and
>5 yr of age), the existence of clusters or epidemics with a
wave-like spread, all suggest that KD is related to infectious
agents, particularly of viral origin. On the other hand, the
elevated levels of the inflammatory indices including the
white blood cell (WBC) and neutrophil count and the C-reac-
tive protein (CRP) suggest that bacterial agents including
superantigens are involved in KD (4). We previously found
that the IgM and IgA levels increased at 1 week and 2 weeks
after intravenous immunoglobulin (IVIG) treatment with a
statistical significance (5). This finding also provides evidence
showing that KD is an infection-related disease.
Many therapeutic modalities have been attempted in order
to prevent the coronary artery lesions (CAL) as the major com-
plication of KD. IVIG therapy is known to decrease the num-
bers of CAL, and is now accepted as standard treatment for
KD (6, 7). Therefore, a study on the natural course in KD is
unethical and impossible. 
The total duration of fever in KD in the era before IVIG
therapy was reported to be approximately 1-2 weeks (mean 10
days) regardless of treatments with aspirin or steroids (1, 8).
We evaluated the inflammatory indices including the WBC
count and CRP according to the onset of fever in children
with KD, and postulated that inflammatory processes in KD
reach a peak at the sixth day of fever.
MATERIALS AND METHODS
The subjects of this study were 152 children who had been
diagnosed with KD (82 boys and 70 girls) between July 1999
and December 2002 at The Catholic University of Korea,
Daejeon St. Mary’s Hospital. The diagnostic criteria were
based on the Diagnostic Guidelines of Kawasaki Disease pre-
sented by the Japan Kawasaki Disease Research Committee
(9). The first day of fever was considered the first day of illness.
The mean age of the patients was 2.4±1.4 yr (2 months-
9.4 yr). One hundred nineteen children met the criteria for
KD and 33 cases of an incomplete KD were included. Incom-
plete KD patient was defined as those who do not fulfil the
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Inflammatory Processes in Kawasaki Disease Reach their Peak at the
Sixth Day of Fever Onset: Laboratory Profiles According to Duration
of Fever
We evaluated the inflammatory indices according to the fever duration in children
with Kawasaki disease (KD), and determined duration when the inflammatory pro-
cesses in KD reach their peak. Children with KD (n=152) were classified into 7
groups according to fever duration: at the third day or earlier (n=20), fourth (n=33),
fifth (n=46), sixth (n=15), seventh (n=15), eighth (n=9), and at the ninth day or later
after fever onset (n= 14). The levels of various laboratory indices were determined
3 times: before, 24 hr and 7 days after intravenous immunoglobulin administration
(2 g/kg). WBC and neutrophil counts, and C-reactive protein level were the highest
at the sixth day. Levels of hemoglobin, albumin, and high density lipoprotein chole-
strol were the lowest at the sixth day. Although these indices were not significant
statistically between groups, the indices showed either bell-shaped or U-shaped
distribution of which peak or trench were at the sixth day. These findiugs showed
that the inflammatory processes in KD reach peak on the sixth day of fever onset.
This finding is important because a higher single-dose intravenous immunoglobulin
treatment before the peak day may help reduce the coronary artery lesions in KD.
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recommended criteria at presentation regardless of echocardio-
graphic findings. All patients with incomplete presentation
who did not show elevated CRP (<2.0 mg/dL), and WBC
and neutrophil (<10,000/ L and <5,000/ L, respectively)
levels with repeated examinations in the earlier days of ill-
ness or those who did not show an increased platelet count
7 days after IVIG treatment were excluded (4 cases). Children
were treated with IVIG (I.V.-Globulin S, Green Cross, Korea:
5% liquid preparation containing only maltose, IgG:mal-
tose=1:2) at a dose of 2 g/kg over 12 hr and a dose of aspirin
(30-40 mg/kg) during the febrile period. After obtaining
parental consent, the serial examinations were performed three
times during admission: before IVIG administration, and 24
hr and 7days after IVIG administration. CAL were defined
and classified as follows: ectasia was defined when coronary
arterial dilatation with the diameter ≤4 mm was seen or
when the diameter was less than 1.5 times than that of adja-
cent artery diameter; aneurysm, when dilatation >4 mm ecta-
sia with or without, multiple, pyramidal/fusiform aneurysm
was present. Twenty-six of the 152 children had CAL (21 in
ectasias and 5 in aneurysms). Thirteen children showed a resis-
tance to IVIG therapy (a fever for more than 48 hr after initi-
ating the IVIG infusion). These children were not excluded
from the study group. The demographic and laboratory data
were tabulated. The Ethics Committee on Clinical Research,
the Catholic University of Korea, approved this study. 
Statistical analyses were done using SPSS 10.0 for Win-
dows. The means of all continuous variables were compared
using one way ANOVA, Fisher’s extact test and chi-square
test. Continuous variables are reported as the mean±Stan-
dard deviation. p≤0.05 was considered statistically signifi-
cant.
RESULTS
The demographic and clinical characteristics of the patients
are summarized in Table 1. There were no significant differ-
ences in terms of age (mean 28.4±16.2 months) and sex
distribution (male to female ratio, 82:70) among the groups.
The mean total duration of the fever was 7.3±1.9 days. The
mean incidence of CAL evaluated within 2-3 weeks of the
onset of fever was 17.1%. There was a trend for the incidence
of CAL to be higher in the sixth day (40%) and the ≥ninth
day groups (42.9%) than the other groups. No significant
differences were observed among the groups in the cases of
Parameters
Days of fever
≤3 (n=20) 4 (n=33) 5 (n=46) 6 (n=15) 7 (n=15) 8 (n=9) ≥9 (n=14)
Total (n=152)
Mean age (mon) 21.9±14.5 28.2±16.1 29.2±15.8 30.5±18.0 28.8±14.2 20.7±9.4 38.4±23.9 28.4±16.2
Male/female (No.) 10/10 17/16 25/21 6/9 9/6 6/3 9/5 82/70
Fever duration (day) 5.3±1.3 5.4±0.8 6.4±1.1 7.1±0.9 7.9±0.9 10.1±3.5 12.6±2.3* 7.3±1.9
CAL (No, %)
� 1 (5.0)* 3 (9.1)* 7 (15.2) 6 (40) 1 (6.7) 2 (22.2) 6 (42.9) 26 (17.1)
IVIG retreatment (No, %)
� 3 (15) 1 (3.0) 3 (6.5) 2 (13.5) 1 (6.7) 1 (11.1) 2 (14.3) 13 (8.5)
Incomplete KD (No, %) 7 (35) 3 (9) 7 (15) 3 (20) 4 (27) 3 (33) 6 (43) 33 (22)
Table 1. Clinical and demographic characteristics of Kawasaki disease patients according to fever duration
*Statistically significant (p<0.05) compared to the values at the sixth day; 
�
, Coronary artery lesions; 
�
, Intravenous immunoglobulin retreatment.
Parameters
WBC (/ L, ×10
3) 14.5±3.5 16.1±4.5 14.4±3.0 17.1±6.3 14.0±4.2 15.0±4.3 14.4±4.7 15.0±4.1
Neutrophil (/ L, ×10
3) 9.7±1.6 10.3±1.9 9.8±1.2 11.5±1.9 8.6±2.2 8.6±1.7 8.1±1.7 9.6±1.7
Hemoglobin (g/dL) 10.9±0.6 11.3±0.8 10.8±0.7 10.5±0.6 10.8±0.6 10.8±0.6 10.5±0.8 10.9±0.7
Platelet (/ L, ×10
3) 358±83 387±73 360±77 370±91 423±139 509±123 525±175* 396±105
ESR (mm/hr) 45.6±6.9 43.7±10.2 48.2±8.6 47.0±12.9 46.6±12.0 51.2±10.4 40.8±9.9 46.2±9.8
CRP (mg/dL) 7.5±3.6 6.1±3.8* 11.0±5.9 14.5±7.1 11.2±4.4 6.3±3.3* 7.3±3.4 9.1±5.6
AST (IU/L) 93±83 52±33 54±45 41±27 38±17 39±25 33±15 53±40
ALT (IU/L) 128±100 97±98 84±85 71±48 56±38 31±26 19±11 83±77
LDH (IU/L) 542±201 512±79 490±123 488±83 559±98 580±111 484±67 512±111
CPK (IU/L) 72±25 104±57 105±80 108±111 96±66 74±32 79±61 95±64
T. protein (g/dL) 6.1±0.5 6.5±0.4 6.5±0.5 6.4±0.7 6.4±0.4 6.9±0.5 6.7±0.4 6.5±0.5
Albumin (g/dL) 3.7±0.3 3.8±0.4 3.7±0.4 3.4±0.4 3.6±0.3 3.9±0.4 3.7±0.3 3.7±0.4
T. chol (mg/dL) 127±22 144±19 145±17 141±19 154±24 155±22 163±26 144±21
HDL-chol (mg/dL) 33.6±6.4 30.7±5.8 32.5±8.5 28.1±9.0 33.0±9.2 34.1±6.9 34.8±6.8 32±8.1
Table 2. Laboratory data of Kawasaki disease patients according to fever duration
T. protein, total protein; T. chol, total cholesterol; HDL-chol, HDL-cholesterol. *Statistically significance (p<0.05) compared to the values at sixth day.
Days of fever
≤3 (n=20) 4 (n=33) 5 (n=46) 6 (n=15) 7 (n=15) 8 (n=9) ≥9 (n=14)
Total (n=152)IVIG retreatment. Twenty-two percent of cases had fever with
less than 4 of the diagnostic criteria for KD at presentation
(incomplete KD). There was a trend for the incidence of in-
complete KD to be higher in the ≤third day (35%), the
eighth day (33%) and the ≥ninth day groups (43%).
The laboratory findings obtained before IVIG treatment
are summarized in Table 2. WBC and neutrophil counts, CRP
and creatine phosphokinase (CPK) values were the highest in
the sixth day group, and the last two indices showed a bell-
shaped distribution pattern based on the peak sixth day values.
In contrast, albumin, and HDL-cholesterol values were the
lowest in the sixth day group, and they showed a pattern of
U-shaped distribution. The platelet count and total cholesterol
value showed a trend for increase with subsequent days of
fever. The hemoglobin, ESR and LDH values did not change
significantly. The AST and ALT values were the highest in
the ≤third day group, but were not statistically significant. 
DISCUSSION
The inflammatory processes of an infection progress to a
peak stage, then regress to a convalescence by host immune
response. The total duration of fever in most uncomplicated
viral infections is approximately 1 week, including measles
(5 days) and Epstein-Barr virus infection (6 days). On the other
hand, the duration of fever in an untreated bacterial infection
differs according to the causative agent. Scarlet fever is known
to last 5-7 days. However causative disease caused by intra-
cellular organisms such as typhoid fever lasts much longer
(>2 weeks). 
Early studies revealed that the total duration of KD with-
out IVIG therapy was 1-2 weeks (mean 10 days) (1, 8). There-
fore,it is postulated that the peak inflammatory process in KD
is at the fifth to sixth day after the onset of fever. The results
in this study shows that the levels of inflammatory indices
reach a peak or nadir on the sixth day of the fever, which agrees
with the above postulation. WBC and neutrophil counts, ESR
and CRP levels are commonly used as indices of severity of
inflammation. CRP increases rapidly within 24 hr in various
conditions, like bacterial infections, trauma, tissue necrosis,
and malignant neoplasm. It declines rapidly with a resolu-
tion of the pathologic conditions (10). ESR is also another
acute reactant of inflammation. The decreased albumin or
HDL-cholesterol values have been reported in inflammatory
diseases including KD (11, 12). Although, this study could
not show difference of statistical significance in any of the
indices between groups, the distribution patterns of these
indices strongly support our postulation. AST and ALT val-
ues appeared to be higher in the early days of the natural course
in KD. The cases with elevated AST and ALT above two folds
the normal values were also higher in the early days of the
fever (≤4 day, 20 of 50 cases) than in the later days (≥7 days,
5 of 38 cases). A decreased total cholesterol level in the earli-
er days tends to increase with days of the fever. The platelet
count is well known to increase in the convalescent stage in
KD. The platelet counts also tended to increase by days of
fever in the acute stage. 
Recently, two studies reported the relationship between the
initial day of the IVIG treatment and the clinical or laboratory
outcomes in KD (13, 14). Although the two studies are simi-
lar in study design, the results of CAL frequency and labora-
tory findings were not identical. Nomura et al. (13) reported
that the group receiving IVIG treatment prior to the fifth
day of illness showed a higher CAL at 1 month, and no dif-
ferences in the laboratory findings except for ALT and AST
when compared to those given IVIG after the fifth day. In con-
trast, Tse et al. (14) reported a case-control study showing that
early IVIG treatment at day 5 or earlier showed a lower inci-
dence of CAL at 1 yr, and some differences in the laboratory
findings including higher hemoglobin, ALT, and albumin
values and lower platelet count. If our postulation is correct,
different results of laboratory study between the two groups
might result from differences in the number of patients in
each different fever day.
Earlier studies have reported that the risk of CAL in KD is
associated with some demographic or laboratory factors such
as the prolonged fever duration, or an increased CRP (15-17).
IVIG is quite effective for improving the clinical symptoms
as well as the laboratory findings including CRP, and for pre-
venting coronary complications (6, 7). We previously repored
that a high dose IVIG treatment (2 g/kg) lowered the values
of various proteins including albumin and lipoproteins, and
also values of the inflammatory indices within 24 hr except
ESR (5, 18). In addition, we also found that IVIG-resistant
patients showed a sustained high values of CRP and WBC
on 24 hr after IVIG with a higher risk of CAL (19, 20). If the
risk of CAL is associated with the intensity of the inflamma-
tion reflected by laboratory indices, early treatment prior to
the peak stage of inflammation can help prevent CAL in KD.
There are some limitations in interpreting our results. Be-
cause the data had a large number of variables (seven variables)
and an uneven distribution of the number of variables, our
postulation could not reach statistical significance. A prospec-
tive study with a large number of patients would resolve this.
A diagnosis of KD in patients before 5 days illness could not
fulfil the diagnostic criteria and those with incomplete KD
were included in this study. All patients with incomplete KD
were selected on the basis of the laboratory findings as des-
cribed earlier as well as the clinical criteria. However, there
was no significant difference in laboratory values between
the incomplete KD group and typical KD group (data not
shown).
In conclusion, it is very important to determine when the
inflammatory processes of KD reach a peak as a self-limiting
disease. As for the coronary complications in KD, it is believed
that the more severe inflammatory processes, which are reflect-
ed by prolonged fever duration or higher values of the inflam-
Peak day of Inflammation in Kawasaki Disease 503504 K.-Y. Lee, J.-W. Han, J.-H. Hong, et al.
matory indices, have a higher risk. Therefore a higher single-
dose IVIG treatment before the peak stage of KD may help
reduce the intensity of inflammation and the frequency of
CAL. Repeated examination of the inflammatory indices can
help decide the timing for appropriate IVIG treatment for
children with an incomplete presentation in the earlier days,
and for evaluating the effects of IVIG treatment. 
REFERENCES
1. Kawasaki T. Acute, febrile mucocutaneous syndrome with lymphoid
involvement with specific desquamation of the fingers and toes in
children. Jpn J Allergy (Arerugi) 1967; 16: 178-222.
2. Sundel RP, Newberger JW. Kawasaki disease. Curr Opin Infect Dis
1992; 5: 664-9.
3. Rowley AH, Gonzalez-Crussi F, Shulman ST. Kawasaki syndrome.
Rev Infect Dis 1988; 10: 1-15.
4. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung
DY. Selective expansion of T cells expressing T-cell receptor variable
regions V 2 and V 8 in Kawasaki disease. Proc Natl Acad Sci USA
1992; 89: 4066-70.
5. Lee KY, Lee HS, Hong JH, Han JW, Lee JS, Whang KT. High-dose
intravenous immunoglobulin down-regulates the activated levels of
inflammatory indices except erythrocyte sedimentation rate in acute
stage of Kawasaki disease. J Trop Pediatr 2004; in press.
6. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Haya-
shidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T. High dose
intravenous gamma globulin for Kawasaki disease. Lancet 1984; 2:
1055-8.
7. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung
KJ, Colan SD, Duffy CE, Fulton DR, Glode MP. A single intravenous
infusion of gamma globulin as compared with four infusions in the
treatment of Kawasaki syndrome. N Engl J Med 1991; 324: 1633-9. 
8. Hicks RV, Melish ME. Kawasaki syndrome; Rheumatic complains
and analysis of salicylate therapy. Arthritis Rheum 1979; 22: 621-2.
9. Japan Kawasaki Disease Research Committee. Diagnostic guidelines
of Kawasaki disease. 4th ed. Tokyo: Japan Kawasaki Disease Research
Committee, 1984.
10. Kushner I. C-reactive protein and the acute-phase response. Hosp
Pract 1990; 25: 21-8.
11. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR.
Changes in serum lipoprotein pattern induced by acute infection.
Metabolism 1988; 37: 859-65.
12. Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid pro-
file after Kawasaki syndrome. Circulation 1991; 84: 625-31.
13. Nomura Y, Masuda K, Yoshinaga M, Sameshima K, Miyata K. Pa-
tients diagnosed with Kawasaki disease before the fifth day of illness
have a high risk of coronary artery aneurysm. Pediatr Intern 2002;
44: 353-7.
14. Tse SML, Silverman ED, McCrindle BW, Yeung RSM. Early treat-
ment with intravenous immunoglobulin in patients with Kawasaki
disease. J Pediatr 2002; 140: 450-5.
15. Koren G, Lavi S, Rose V, Rowe R: Kawasaki disease: review of risk
factors for coronary aneurysms. J Pediatr 1986; 108: 388-92. 
16. Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW. A
predictive instrument for coronary artery aneurysms in Kawasaki
disease. Am J Cardiol 1998; 81: 1116-20.
17. Koyanagi H, Nakamura Y, Yanagawa H. Lower level of serum potas-
sium and higher level of C-reactive protein as an independent risk
factor for giant aneurysms in Kawasaki disease. Acta Paediatr 1998;
87: 32-6.
18. Lee KY, Han JW, Lee JS, Whang KT. Alteration of biochemical pro-
files after high-dose intravenous immunoglobulin administration in
Kawasaki disease. Acta Paediatr 2002; 91: 164-7. 
19. Lee GB, Lee JW, Lee KY. Prediction of intravenous immunoglobu-
lin non-responders in patients with Kawasaki disease. Korean J Pedi-
atr 2004; 47: 90-4.
20. Lee KY, Han JW, Lee HS, Hong JH, Hahn SH, Lee JS, Whang KT.
Epidemiologic study of Kawasaki disease at a single hospital in Dae-
jeon, Korea (1987 through 2000). Pediatr Infect Dis J 2004; 23: 52-5.